Clinical Trials Directory

Trials / Unknown

UnknownNCT05394896

Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant (HPI2022)

Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant: an Explorative, Monocentric, RCT

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

HPI monitoring and the adoption of therapeutic interventions before hypotension occurs should be ensure a shorter time of intra-operative hypotension (MAP \< 65 mmHg) during deceased-donor kidney transplant surgery. The control group is represented by patients undergoing the same surgical procedure with hemodynamic monitoring with invasive blood pressure monitoring which represents the gold standard for this surgery. HPI monitoring has not yet been investigated during this surgery.

Conditions

Interventions

TypeNameDescription
DEVICEACUMEN (Edwards Lifesciences, Irvine, USA)ACUMEN sensor generates HPI index which should predict hypotension. Based on HPI index, Eadyn and dP/dTmax values anaesthesia should somministrate liquid or drugs to prevent hypotension.
DEVICEInvasive Blood PressureInvasive Blood Pressure permits continue monitoring of blood pressure (routine standard for kidney transplant surgery)

Timeline

Start date
2022-11-01
Primary completion
2023-11-30
Completion
2024-01-31
First posted
2022-05-27
Last updated
2023-01-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05394896. Inclusion in this directory is not an endorsement.